Advisory Committee on the Medical Uses of Isotopes: Meeting Notice, 21268-21269 [2015-08935]
Download as PDF
21268
Federal Register / Vol. 80, No. 74 / Friday, April 17, 2015 / Notices
tkelley on DSK3SPTVN1PROD with NOTICES
was approved for Hematite License
Amendment 60, and the 22,000 m3
(29,000 yd3) of LLRW that was approved
for Hematite License Amendment 63. As
such, the cumulative impacts on the
USEI facility and surrounding
environment resulting from the receipt
of the waste material described in the
aforementioned license amendments
were considered.
In 2002, WEC and the Missouri
Department of Natural Resources
(MDNR) entered into a Letter
Agreement, which, among other things,
provided for MDNR oversight of certain
studies and response actions in
accordance with the National Oil and
Hazardous Substances Pollution
Contingency Plan under the
requirements of the Comprehensive
Environmental Response,
Compensation, and Liability Act
(CERCLA), 42 U.S.C. 9601 et seq.
(Westinghouse MDNR Review Draft
Remedial Design Work Plan, 2002).
On July 3, 2008, Missouri and WEC
entered into a Consent Decree, and the
Letter Agreement was terminated. The
Consent Decree provides for MDNR
oversight of those portions of the
investigation and selection of the
remedy for Operable Units at the site
that are not preempted by the Atomic
Energy Act of 1954, as amended. The
Selected Remedy for Operable Unit 1 at
the HDP is Alternative 4: Removal,
Treatment of Volatile Organic
Compound Waste, and Off-site Disposal
of Low-Level Radioactive Waste and
Non-Hazardous Treatment Residues.
Environmental Impacts of the
Alternatives to the Proposed Action
As an alternative to the proposed
action, the staff considered denial of the
proposed action (i.e., the ‘‘no-action’’
alternative). The no-action alternative
involves discontinuing ongoing
decommissioning activities at the HDP
and leaving contaminated soil and other
radioactive waste at the HDP site. This
action would require an exemption from
the requirement in 10 CFR 70.38(d) that
decommissioning of facilities
specifically licensed for possession and
use of special nuclear material be
completed and approved by the NRC
after licensed activities cease. The noaction alternative would result in
leaving approximately 87,100 m3 of
total waste volume onsite.
As was previously noted, the
radioactive waste, regulated by the NRC,
is co-mingled with chemically
contaminated waste regulated under
CERCLA. The no-action alternative
would not be in accordance with the
July 2009 CERCLA Record of Decision
(https://www.dnr.mo.gov/env/hwp/docs/
VerDate Sep<11>2014
01:21 Apr 17, 2015
Jkt 235001
20090721HRSFINALROD.pdf) for the
removal and subsequent treatment of
the chemically contaminated waste.
The no-action alternative would not
allow WEC to meet the requirements of
10 CFR 20.1402 for unrestricted release.
Selection of this alternative would
require WEC to continue environmental
monitoring/surveillance and to maintain
administrative and engineered controls
to ensure facility safety and security.
The environmental impacts of the noaction alternative would include
continued contamination of soil and
water, which could further escalate over
time if groundwater contamination
spreads and material such as
Technicium-99 continue to leach into
the soil. The continued monitoring
required at the site would result in
environmental impacts due to the
emissions from vehicular traffic
associated with workers traversing to
and from the site and entities providing
services and supplies to the Hematite
facility. Additional vehicular traffic
could also impact public and
occupational health with the potential
for vehicle accidents.
Another alternative to the proposed
action is to dispose of the LLRW in a
facility licensed by an NRC Agreement
State for the storage and/or disposal of
LLRW. For this EA, the NRC evaluated
the EnergySolutions, LLC
(EnergySolutions) Clive, Utah, facility as
the alternative disposal site for the
radioactive and chemically hazardous
waste.
The EnergySolutions LLRW disposal
facility at Clive, Utah, is located 128
kilometers (80 miles) west of Salt Lake
City, Utah, and 70 kilometers (45 miles)
east of Wendover, Nevada. The site is
arid with an annual precipitation of
approximately 20 centimeters (8
inches). The facility is licensed by the
State of Utah, to dispose of Class A
radioactive waste only (Utah License
2300249) and 11e.(2) byproduct material
(UT2300478) and holds a Part B
Resource Conservation and Recovery
Act (RCRA) solid waste permit
(Environmental Protection Agency ID
No. UTD982598898).
The selection of this alternative
would allow WEC to meet the
requirements of 10 CFR 20.1402 for
unrestricted release. In addition, this
site is environmentally similar to USEI.
However, this alternative was not
selected by WEC.
Alternative Use of Resources
The proposed action does not impact
any resource implications discussed in
previous environmental reviews.
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
Agencies and Persons Consulted
In accordance with its stated policy,
the NRC staff consulted with the
Missouri Department of Conservation,
Idaho Department of Fish and Game,
and U.S. Fish and Wildlife Service
during the development of this EA. On
January 14, 2015, the NRC staff
consulted with MDNR and IDEQ
regarding the environmental impact of
the proposed action and solicited
comments on a draft EA and FONSI. No
comments were received.
lIl. Finding of No Significant Impact
WEC has requested NRC authorization
under 10 CFR 20.2002 for the alternate
disposal of an additional 87,100 m3 of
radioactive waste consisting of buried
debris and contaminated soil, concrete
and asphalt, filter media, ion exchange
resin and piping containing NRClicensed source, byproduct, and special
nuclear material. In addition, both WEC
and USEI have requested that the NRC
exempt USEI from the requirements of
10 CFR 30.3 and 10 CFR 70.3.
Consistent with 10 CFR 51.21, the NRC
conducted the EA for the proposed
action described Section II of this
document and publicly available in
ADAMS (ADAMS Accession No.
ML15029A064). The EA is incorporated
by reference in this finding. On the basis
of the EA, the NRC concludes that the
proposed action will not have a
significant effect on the quality of the
human environment. Accordingly, the
NRC has determined not to prepare an
environmental impact statement for the
proposed action.
Dated at Rockville, Maryland this 8th day
of April 2015.
For The Nuclear Regulatory Commission.
Andrew Persinko,
Deputy Director, Division of
Decommissioning, Uranium Recovery, and
Waste Programs, Office of Nuclear Material
Safety and Safeguards.
[FR Doc. 2015–08933 Filed 4–16–15; 8:45 am]
BILLING CODE 7590–01–P
NUCLEAR REGULATORY
COMMISSION
Advisory Committee on the Medical
Uses of Isotopes: Meeting Notice
U.S. Nuclear Regulatory
Commission.
ACTION: Notice of meeting.
AGENCY:
The U.S. Nuclear Regulatory
Commission will convene a
teleconference meeting of the Advisory
Committee on the Medical Uses of
Isotopes (ACMUI) on August 12, 2015,
to discuss the ACMUI Germanium/
SUMMARY:
E:\FR\FM\17APN1.SGM
17APN1
Federal Register / Vol. 80, No. 74 / Friday, April 17, 2015 / Notices
Gallium-68 subcommittee report.
Meeting information, including a copy
of the agenda and handouts, will be
available at https://www.nrc.gov/readingrm/doc-collections/acmui/meetings/
2015.html. The agenda and handouts
may also be obtained by contacting Ms.
Sophie Holiday using the information
below.
The teleconference meeting will
be held on Wednesday, August 12,
2015, 2:00 p.m. to 4:00 p.m. Eastern
Standard Time.
Public Participation: Any member of
the public who wishes to participate in
the teleconference should contact Ms.
Holiday using the contact information
below.
Contact Information: Ms. Sophie
Holiday, U.S. Nuclear Regulatory
Commission, Office of Nuclear Material
Safety and Safeguards; by telephone:
(404) 997–4691; or by email:
sophie.holiday@nrc.gov.
DATES:
Conduct of the Meeting
tkelley on DSK3SPTVN1PROD with NOTICES
Dr. Bruce Thomadsen, ACMUI
Chairman, will preside over the
meeting. Dr. Thomadsen will conduct
the meeting in a manner that will
facilitate the orderly conduct of
business. The following procedures
apply to public participation in the
meeting:
1. Persons who wish to provide a
written statement should submit an
electronic copy to Ms. Holiday at the
contact information listed above. All
submittals must be received by August
07, 2015, three business days prior to
the meeting, and must pertain to the
topic on the agenda for the meeting.
2. Questions and comments from
members of the public will be permitted
during the meetings, at the discretion of
the Chairman.
3. The draft transcript and meeting
summary will be available on ACMUI’s
Web site https://www.nrc.gov/readingrm/doc-collections/acmui/meetings/
2015.html on or about September 24,
2015.
This meeting will be held in
accordance with the Atomic Energy Act
of 1954, as amended (primarily section
161a); the Federal Advisory Committee
Act (5 U.S.C. App); and the
Commission’s regulations in title 10 of
the Code of Federal Regulations part 7.
Dated at Rockville, Maryland, this 13th day
of April 2015.
For the Nuclear Regulatory Commission.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. 2015–08935 Filed 4–16–15; 8:45 am]
BILLING CODE 7590–01–P
VerDate Sep<11>2014
01:21 Apr 17, 2015
Jkt 235001
NUCLEAR REGULATORY
COMMISSION
[Docket No. 52–016; NRC–2008–0250]
UniStar Nuclear Energy; Combined
License Application for Calvert Cliffs
Nuclear Power Plant, Unit 3
Nuclear Regulatory
Commission.
ACTION: Exemption; issuance.
AGENCY:
The U.S. Nuclear Regulatory
Commission (NRC) is issuing an
exemption in response to a December
31, 2014, letter from UniStar Nuclear
Energy (UNE), on behalf of Calvert Cliffs
Nuclear Project, LLC, and UniStar
Operating Services, LLC, co-applicants
for the combined license (COL)
application for the Calvert Cliffs Nuclear
Power Plant Unit 3 (CCNPP3), which
requested an exemption to delay the
submission of the annual update of the
Final Safety Analysis Report (FSAR) to
be included in their COL application.
The NRC staff reviewed this request and
determined that it is appropriate to
grant the exemption to delay the FSAR
update submittal up to December 31,
2015.
ADDRESSES: Please refer to Docket ID
NRC–2008–0250 when contacting the
NRC about the availability of
information regarding this document.
You may access the publicly-available
information related to this document
using any of the following methods:
• Federal Rulemaking Web site: Go to
https://www.regulations.gov and search
for Docket ID NRC–2008–0250. Address
questions about NRC dockets to Carol
Gallagher; telephone: 301–415–3463;
email: Carol.Gallagher@nrc.gov. For the
technical questions, contact the
individual listed in the FOR FURTHER
INFORMATION CONTACT section of this
document.
• NRC’s Agencywide Documents
Access and Management System
(ADAMS): You may obtain publiclyavailable documents online in the
ADAMS Public Documents collection at
https://www.nrc.gov/reading-rm/
adams.html. To begin the search, select
‘‘ADAMS Public Documents’’ and then
select ‘‘Begin Web-based ADAMS
Search.’’ For problems with ADAMS,
please contact the NRC’s Public
Document Room (PDR) reference staff at
1–800–397–4209, 301–415–4737, or by
email to pdr.resource@nrc.gov. The
ADAMS accession number for each
document referenced in this document
(if that document is available in
ADAMS) is provided the first time that
a document is referenced.
• NRC’s PDR: You may examine and
purchase copies of public documents at
SUMMARY:
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
21269
the NRC’s PDR, Room O1–F21, One
White Flint North, 11555 Rockville
Pike, Rockville, Maryland 20852.
FOR FURTHER INFORMATION CONTACT:
Surinder Arora, Office of New Reactors,
U.S. Nuclear Regulatory Commission,
Washington, DC 20555–0001; telephone:
301–415–1421, or email:
Surinder.Arora@nrc.gov.
SUPPLEMENTARY INFORMATION:
I. Background
On March 14, 2008, UNE, on behalf of
Calvert Cliffs Nuclear Project, LLC and
UniStar Operating services, LLC,
submitted to the NRC a COL
application, under subpart C of part 52
of Title 10 of the Code of Federal
Regulations (10 CFR) to construct and
operate a single unit of AREVA NP’s
U.S. Evolutionary Power Reactor (EPR),
designated as Calvert Cliffs Nuclear
Power Plant Unit 3, at a site in Calvert
County, Maryland. The UNE application
was docketed on June 3, 2008 (Docket
Number 52–016). UNE’s COL
application for CCNPP3 incorporates by
reference AREVA NP’s application for a
standard design certification for the U.S.
EPR. The NRC is currently performing
concurrent reviews of the CCNPP3 COL
application as well as AREVA NP’s
application for design certification of
the U.S. EPR. UNE also had previously
requested an exemption on November
19, 2013 (this request was later
supplemented by UNE’s follow up
updated request on March 21, 2014),
under 10 CFR 50.71(e)(3)(iii) to submit
the scheduled 2013 FSAR update, and
proposed, for approval, a new submittal
deadline of December 31, 2014. The
NRC reviewed the bases for the
exemption request and granted the
exemption as described in Federal
Register notice published on September
11, 2014 (79 FR 54303).
By a letter dated December 16, 2014
(ADAMS Accession No. ML14351A301),
UNE requested that after January 2015,
the NRC defer its safety review portion
of the Calvert Cliffs Unit 3 COL
application until such time that UNE
formally requests that the NRC resume
its review. The letter also stated that
UNE will monitor and evaluate progress
of the technical issue resolution for the
U.S. EPR FSAR and the development of
guidance necessary to address Foreign
Ownership Control and Domination
(FOCD) prior to requesting the NRC to
resume review. By letter dated February
27, 2015 (ADAMS Accession No.
ML15062A050), UNE requested that
after March 6, 2015, the NRC suspend
the Calvert Cliffs Unit 3 COL
application review until such time the
UNE formally requests that the NRC
E:\FR\FM\17APN1.SGM
17APN1
Agencies
[Federal Register Volume 80, Number 74 (Friday, April 17, 2015)]
[Notices]
[Pages 21268-21269]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-08935]
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
Advisory Committee on the Medical Uses of Isotopes: Meeting
Notice
AGENCY: U.S. Nuclear Regulatory Commission.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: The U.S. Nuclear Regulatory Commission will convene a
teleconference meeting of the Advisory Committee on the Medical Uses of
Isotopes (ACMUI) on August 12, 2015, to discuss the ACMUI Germanium/
[[Page 21269]]
Gallium-68 subcommittee report. Meeting information, including a copy
of the agenda and handouts, will be available at https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2015.html. The agenda and
handouts may also be obtained by contacting Ms. Sophie Holiday using
the information below.
DATES: The teleconference meeting will be held on Wednesday, August 12,
2015, 2:00 p.m. to 4:00 p.m. Eastern Standard Time.
Public Participation: Any member of the public who wishes to
participate in the teleconference should contact Ms. Holiday using the
contact information below.
Contact Information: Ms. Sophie Holiday, U.S. Nuclear Regulatory
Commission, Office of Nuclear Material Safety and Safeguards; by
telephone: (404) 997-4691; or by email: sophie.holiday@nrc.gov.
Conduct of the Meeting
Dr. Bruce Thomadsen, ACMUI Chairman, will preside over the meeting.
Dr. Thomadsen will conduct the meeting in a manner that will facilitate
the orderly conduct of business. The following procedures apply to
public participation in the meeting:
1. Persons who wish to provide a written statement should submit an
electronic copy to Ms. Holiday at the contact information listed above.
All submittals must be received by August 07, 2015, three business days
prior to the meeting, and must pertain to the topic on the agenda for
the meeting.
2. Questions and comments from members of the public will be
permitted during the meetings, at the discretion of the Chairman.
3. The draft transcript and meeting summary will be available on
ACMUI's Web site https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2015.html on or about September 24, 2015.
This meeting will be held in accordance with the Atomic Energy Act
of 1954, as amended (primarily section 161a); the Federal Advisory
Committee Act (5 U.S.C. App); and the Commission's regulations in title
10 of the Code of Federal Regulations part 7.
Dated at Rockville, Maryland, this 13th day of April 2015.
For the Nuclear Regulatory Commission.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. 2015-08935 Filed 4-16-15; 8:45 am]
BILLING CODE 7590-01-P